 |
 |
 |
 |
 |
 |
Duration: 2 hours
Date of Original Release: June 2008
Live Event: April 5, 2008 (satellite symposium)
Expiration Date: June 2009
Type of Media Used: Online HTML Webcast
An On-line HTML Webcast Version of the Live Satellite Symposium which took place on April 5, 2008 and Presented at Hospital Medicine 2008 - SHM's Annual Meeting
For questions regarding this CME activity, please contact:
Jennifer Jones
Postgraduate Institute for Medicine
367 Inverness Parkway, Suite 215
Englewood, CO 80112
Phone: (720) 895-5333
Fax: (303) 858-8848
E-mail: jjones@pimed.com
www.pimed.com
Statement of Need
A decade has passed since a few pioneering hospitals embraced the concept of the Hospitalist, and those early adopters feel the practice is a success and will continue to grow. Hospitalists are becoming experts in the conditions they treat, including heart failure, and are more committed to improving hospital processes that result in efficiencies as well as freeing primary care physicians from having to come into a hospital to make patient rounds.
Hospitalists are integral in providing clinical guidance regarding intervention strategies to alleviate and possibly obviate the detrimental effects and outcomes of acute decompensated heart failure (ADHF). Consequently, providing educational programs to this audience will serve to facilitate a greater understanding of the spectrum of ADHF, its clinical manifestations, and evidence-based treatment strategies that optimize patient outcomes.
Learning Objectives
Upon completion of this symposium, participants should be better able to:
- Identify various presentations of ADHF
- Explain the concept "Time Is Function" in ADHF management to compel Hospitalists to treat early, efficiently, and effectively
- Reinforce the efficacy, safety, and therapeutic impact of various ADHF intervention strategies based on patient ADHF characteristics and current and emerging evidence
- Review evidence-based use of pharmacologic agents, including the use of vasoactive agents, and treatment strategies for ADHF management
- Describe how to assimilate new clinical data (as available) into ADHF management strategies
- Identify how to manage attendant ADHF comorbidities
- Describe the collaborative effort among medical specialities that is needed to optimize patient outcomes
Target Audience
This activity has been designed to meet the educational needs of Hospitalists and other clinicians involved in the care of patients with ADHF.
Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Postgraduate Institute for Medicine (PIM) and SynerMed® Communications. PIM is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation
Postgraduate Institute for Medicine designates this educational activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) assesses conflict of interest with its instructors, planners, managers and other individuals who are in a position to control the content of CME activities. All relevant conflicts of interest that are identified are thoroughly vetted by PIM for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
| Name of Faculty or Presenter | Reported Financial Relationship |
|---|---|
| Franklin A. Michota, Jr, MD | Consultant for Scios and sanofi-aventis |
| Michael M. Givertz, MD | Nothing to disclose |
The following PIM clinical content reviewers, Jan Hixon, RN; Linda Graham, RN; and Trace Hutchison, PharmD, and the following SynerMed staff, Robin Pearson, Jessica Adickes, Michelle Fox, and writer Josh Paul hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interests related to the content of this CME activity of any amount during the past 12 months.
Method of Participation
There are no fees for participating and receiving CME credit for this activity. During the period June 2008 through June 2009 participants must:
1) Read the learning objectives and faculty disclosures;
2) Study the educational activity;
3) Complete the posttest by recording the best answer to each question in the answer key on the evaluation form;
4) Complete the posttest and evaluation form at: www.cmeuniversity.com.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Institute for Medicine (PIM), SynerMed® Communications, and Scios do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of PIM, and SynerMed® Communications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.